In summary, PRNP gene expression is elevated in CAF subpopulations of pancreatic cancer patients post-chemotherapy, fostering the emergence of EMT-related genes and drug resistance mechanisms. This evidence concerns the gene PRNP and familial pancreatic carcinoma.